Absci Corporation (ABSI) Financial Statements (2024 and earlier)

Company Profile

Business Address 18105 SE MILL PLAIN BLVD
VANCOUVER, WA 98683
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments61,04811,40959,955181,312206,021226,004
Cash and cash equivalents61,04811,40959,955107,324206,021226,004
Short-term investments    73,988  
Receivables3,1571,3261,550210310350
Debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss63,539132,849104,476   
Other undisclosed current assets20,29319,73320,88219,85921,55729,607
Total current assets:148,037165,317186,863201,381227,888255,961
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   7,000   
Operating lease, right-of-use asset4,8865,1065,3195,5975,7086,266
Property, plant and equipment    68,75065,61163,055
Intangible assets, net (including goodwill)49,93872,11572,95773,80074,64375,485
Goodwill  21,33521,33521,33521,33521,335
Intangible assets, net (excluding goodwill)49,93850,78051,62252,46553,30854,150
Restricted cash and investments1,9021,8821,8641,8521,8451,844
Other noncurrent assets1,5401,2221,2821,2911,3411,293
Other undisclosed noncurrent assets47,85050,16645,723(13,284)(10,721)(8,444)
Total noncurrent assets:106,116130,491134,145138,006138,427139,499
TOTAL ASSETS:254,153295,808321,008339,387366,315395,460
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,56420,02222,89322,83922,52432,380
Accounts payable1,8511,9332,4121,8585,4706,739
Accrued liabilities16,71318,08920,48120,98117,05425,641
Deferred revenue5003594456792,7982,791
Debt4,6865,1085,2424,8674,7865,166
Other undisclosed current liabilities1,7341,7121,6901,6431,5841,545
Total current liabilities:25,48427,20130,27030,02831,69241,882
Noncurrent Liabilities
Long-term debt and lease obligation6,6247,5378,73415,62817,11811,501
Long-term debt, excluding current maturities6,3787,1907,9846,5177,125531
Finance lease, liability2463477501,2631,8182,402
Liabilities, other than long-term debt6,6467,1057,5907891,3121,581
Deferred income tax liabilities2232242387561,0851,359
Other liabilities   3533227222
Operating lease, liability6,4236,8817,3177,8488,1758,568
Total noncurrent liabilities:13,27014,64216,32416,41718,43013,082
Total liabilities:38,75441,84346,59446,44550,12254,964
Equity
Equity, attributable to parent215,399253,965274,414292,942316,193340,496
Common stock999999
Additional paid in capital576,492573,335570,454569,365565,444561,029
Accumulated other comprehensive income (loss)(146)(95)(120)26(61)(23)
Accumulated deficit(360,956)(319,284)(295,929)(276,458)(249,199)(220,519)
Total equity:215,399253,965274,414292,942316,193340,496
TOTAL LIABILITIES AND EQUITY:254,153295,808321,008339,387366,315395,460

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues3,3671,2691,5572,3691,002819
Gross profit:3,3671,2691,5572,3691,002819
Operating expenses(46,355)(25,754)(22,650)(30,336)(29,889)(29,622)
Operating loss:(42,988)(24,485)(21,093)(27,967)(28,887)(28,803)
Nonoperating income (expense)1,3271,1371,122396(63)(70)
Other nonoperating income1,5831,4581,409675148125
Interest and debt expense(256)(321)(287)(279)(211)(195)
Loss from continuing operations before equity method investments, income taxes:(41,917)(23,669)(20,258)(27,850)(29,161)(29,068)
Other undisclosed income from continuing operations before income taxes256321287279211195
Loss from continuing operations before income taxes:(41,661)(23,348)(19,971)(27,571)(28,950)(28,873)
Income tax expense (benefit)(11)(7)500312270(621)
Loss from continuing operations:(41,672)(23,355)(19,471)(27,259)(28,680)(29,494)
Loss before gain (loss) on sale of properties:(27,259)(28,680)(29,494)
Net loss available to common stockholders, diluted:(41,672)(23,355)(19,471)(27,259)(28,680)(29,494)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(41,672)(23,355)(19,471)(27,259)(28,680)(29,494)
Comprehensive loss:(41,672)(23,355)(19,471)(27,259)(28,680)(29,494)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(51)25(146)87(38)(10)
Comprehensive loss, net of tax, attributable to parent:(41,723)(23,330)(19,617)(27,172)(28,718)(29,504)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: